Search Within

Daniel R. Zakheim

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Center for Hematologic Malignancies (4)
  4. Executive Committee, Center for Hematologic Malignancies (4)
  5. Hematologic Malignancies, Division of (4)
  6. Sloan Kettering Institute Postdocs (4)

More Groups

People
  1. Ralph Garippa (4)
  2. Marco Vincenzo Russo (3)
  3. Sanjoy Mehta (3)
  4. Alexander Penson (2)
  5. Anas Younes (2)
  6. Benjamin Durham (2)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (1)
Publications
  1. Blood (2)
  2. Journal of the American College of Surgeons (1)
  3. Nature Cancer (1)
  4. Nature Communications (1)
  5. Nature Genetics (1)
Publishers
  1. American Society of Hematology (2)
  2. Nature Publishing Group (2)
  3. Elsevier Science, Inc. (1)
  4. Nature Research (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
    Journal Article

    Wortzel, I.; Seo, Y.; Akano, I.; Shaashua, L.; Tobias, G. C.; Hebert, J.; Kim, K. A.; Kim, D.; Dror, S.; Liu, Y.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Drugs targeting the proteasome and exportin-1 synergize to inhibit well-differentiated liposarcoma cell proliferation
    Meeting Abstract

    Kryeziu, S.; Russo, M. V.; Zakheim, D.; Hu, J.; Garippa, R.; Crago, A. M.
    Journal of the American College of Surgeons (2022)

    Fulltext@MSK | Save
  • TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Journal Article

    Erazo, T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Refermat, A. Y.; Asgari, Z.; Yang, X.; Da Silva Ferreira, M.; Mehta, S.; Russo, M. V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • TP53 mutations and RNA binding protein MUSASHI 2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Meeting Abstract

    Erazo, I. T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Barbash, O.; Refermat, A. Y.; Batlevi, C. L.; Younes, A.; Kharas, M. G.
    Blood (2021)

    Fulltext@MSK | Save
  • Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition
    Journal Article

    Inoue, D.; Polaski, J. T.; Taylor, J.; Castel, P.; Chen, S.; Kobayashi, S.; Hogg, S. J.; Hayashi, Y.; Pineda, J. M. B.; El Marabti, E.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • ZRSR2 mutation induced minor intron retention drives MDS and diverse cancer predisposition via aberrant splicing of LZTR1
    Meeting Abstract

    Inoue, D.; Polaski, J. T.; Taylor, J.; Castel, P.; Chen, S.; Kobayashi, S.; Hogg, S. J.; Hayashi, Y.; Pineda, J. M. B.; Penson, A. V.; more...
    Blood (2020)

    Fulltext@MSK | Save